Hiroshi Yamagami, MD

National Hospital Organization Osaka National Hospital · Kobe City Medical Center General Hospital

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official

all conditions, ClinicalTrials.gov

NIH grants tied to them

NIH RePORTER

Trial papers

PubMed author-name match

Trials

Studies that name Hiroshi Yamagami, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:35 UTC. Open this list on ClinicalTrials.gov

Ph4
NCT03062319 · Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis
National Hospital Organization Osaka National Hospital · terminated · Ischemic Stroke, Atrial Fibrillation, Atherothrombosis · principal investigator
N/A
NCT01261234 · Carotid Artery Stenting With Cilostazol Addition for Restenosis
Kobe City General Hospital · completed · In-stent Restenosis After Carotid Artery Stenting · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

PubMed returned no clinical-trial papers for this author name.